Sr.No.,Schedule Date,Locality,Age,Gender,Modality,Type of Procedure(s) Requested,Type of Test(s) Requested,Test Result(s),Provisional Diagnosis,Principal Diagnosis,Additional Diagnosis,Pregnant Patient,NHIA Patient,Medicine Prescribed,Medicine Dispensed,Occupation,Ward/Room,Date of Admission,Date of Discharge,Outcome of Discharge,Surgical Procedure,Cost of Treatment (GHS ),Admission Type,E-tracking Number
13,31-10-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,31-10-2024,31-10-2024,,,0,OPD,
54,31-10-2024,KWASHIEMAN,57 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,,,,,31-10-2024,31-10-2024,,,0,OPD,
113,31-10-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,31-10-2024,31-10-2024,,,30,OPD,
118,31-10-2024,Amanfrom,57 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"INSULIN SOLUBLE HM100UNITS/ML[  |  |  | BDS |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]","INSULIN SOLUBLE HM100UNITS/ML[  |  |  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,31-10-2024,31-10-2024,,,0,OPD,
131,31-10-2024,,20 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ],,,,31-10-2024,31-10-2024,,,10,OPD,
340,31-10-2024,tetegu,51 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"E78.4 [Other hyperlipidaemia]  ==> OLD, G43.C0 [Periodic headache syndromes in child or adult, not intractable]  ==> NEW",No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 3 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ]",,,31-10-2024,31-10-2024,,,10,OPD,
352,31-10-2024,KASOA,69 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E10.621 [Type 1 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,,,31-10-2024,31-10-2024,,,20,OPD,
375,31-10-2024,AGEGE ZONE SIX,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Retired,,31-10-2024,31-10-2024,,,80,OPD,
503,31-10-2024,GBAWE  JULICART,53 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.31 [Personal history of diabetic foot ulcer]  ==> NEW",No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Nocte |  For 30 Days  ], NIFEDIPINE 30MG SUSTAIN RELEASE[ NIFEMAX SR 30MG | 30MG | Tablet | Mane |  For 30 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE 30MG SUSTAIN RELEASE[ NIFEMAX SR 30MG | 30MG | Tablet ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ]",Teacher,,31-10-2024,31-10-2024,,,0,OPD,
877,30-10-2024,TUBA AGROW FARM,65 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,TRADER,,30-10-2024,30-10-2024,,,60,OPD,
888,30-10-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E10.621 [Type 1 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,30-10-2024,30-10-2024,,,10,OPD,
898,30-10-2024,AWOSHIE,51 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,TRADER,,30-10-2024,30-10-2024,,,60,OPD,
944,30-10-2024,AMASAMAN,65 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,D64.89 [Other specified anemias]  ==> OLD,No,Insured,"FERROUS GLUCONATE  SYRUP[ TOT-HEMA (IN AMPOULES) | 10ML | Syrup | BDS |  For 30 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | Daily |  For 30 Days  ]",,none,,30-10-2024,30-10-2024,,,10,OPD,
959,30-10-2024,TUBA AGROW FARM,65 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",TRADER,,30-10-2024,30-10-2024,,,0,OPD,
994,30-10-2024,KWAHU MPREASO - NEAR STADIUM,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,30-10-2024,30-10-2024,,,10,OPD,
1052,30-10-2024,KANESHIE,51 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,TRADER,,30-10-2024,30-10-2024,,,0,OPD,
1062,30-10-2024,MEPE,51 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.69 [Diabetes mellitus due to underlying condition with other specified complication]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",BUSINESS PERSON,,30-10-2024,30-10-2024,,,0,OPD,
1134,30-10-2024,ACCRA ,69 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> NEW,,No,Insured,"AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 10 Days  ], FERROUS SULPHATE[ FERROUS SULPHATE (60MG ELEMENTAL) | 60mg | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ]","AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], FERROUS SULPHATE[ FERROUS SULPHATE (60MG ELEMENTAL) | 60mg | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,30-10-2024,30-10-2024,,,0,OPD,
1158,30-10-2024,WEIJA,54 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,"AZITHROMYCIN [ AZITHROMYCIN | 500MG | Tablet | OD |  For 3 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ]","AZITHROMYCIN [ AZITHROMYCIN | 500MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",BUILDING CONTRUCTOR,,30-10-2024,30-10-2024,,,335,OPD,
1172,30-10-2024,WEIJA WATER WORKS,72 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,PENSIONEER,,30-10-2024,30-10-2024,,,60,OPD,
1259,30-10-2024,"WEIJA, DJAMAN",60 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | Daily |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 0 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ]",,,,30-10-2024,30-10-2024,,,0,OPD,
1267,30-10-2024,AGEGE ZONE SIX,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Retired,,30-10-2024,30-10-2024,,,60,OPD,
1770,29-10-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,29-10-2024,29-10-2024,,,0,OPD,
1840,29-10-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E10.621 [Type 1 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,29-10-2024,29-10-2024,,,10,OPD,
1848,29-10-2024,SCC 38DELMONT STR,68 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],Unemployed,,29-10-2024,29-10-2024,,,0,OPD,
1849,29-10-2024,DANSOMAN-BEACH,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,29-10-2024,29-10-2024,,,10,OPD,
1853,29-10-2024,GBAWE DOWN,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | OD |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 60 Days  ]","METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,29-10-2024,29-10-2024,,,0,OPD,
1856,29-10-2024,GBAWE,46 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,29-10-2024,29-10-2024,,,10,OPD,
1857,29-10-2024,POKUASE,58 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]",,,,29-10-2024,29-10-2024,,,10,OPD,
1870,29-10-2024,DOMEABRA,42 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E11.10 [Type 2 diabetes mellitus with ketoacidosis without coma]  ==> OLD,,No,Non-Insured,"FLUCLOXACILLIN CAPSULE 250MG[ FLUCLOXACILLIN | 250MG | Capsule | QID |  For 7 Days  ], IBUPROFEN TABLET 400MG[ IBUPROFEN | 400MG | Tablet | TDS |  For 5 Days  ], POVIDONE+METRONIDAZOLE (DREZ) OINTMENT 10G[ DREZ OINTMENT | 10G | Ointment | BDS |  For 5 Days  ]","FLUCLOXACILLIN CAPSULE 250MG[ FLUCLOXACILLIN | 250MG | Capsule ], IBUPROFEN TABLET 400MG[ IBUPROFEN | 400MG | Tablet ], POVIDONE+METRONIDAZOLE (DREZ) OINTMENT 10G[ DREZ OINTMENT | 10G | Ointment ]",business woman,,29-10-2024,29-10-2024,,,100,OPD,
1920,29-10-2024,ABLEKUMA,67 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",Retired,,29-10-2024,29-10-2024,,,0,OPD,
1937,29-10-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,29-10-2024,29-10-2024,,,0,OPD,
1977,29-10-2024,BAWJIASE METHODIST,74 Year(s),Female,EYE CLINIC ,Consultation Adult ,,No Outcome,NA ,E08.319 [Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy without macular edema]  ==> NEW,"H25.813 [Combined forms of age-related cataract, bilateral]  ==> NEW, H40.0 [Glaucoma suspect]  ==> NEW",No,Insured,,,BUSINESS PERSON,,29-10-2024,29-10-2024,,,35,OPD,
2053,29-10-2024,NEW BORTIANOR,64 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,business woman,,29-10-2024,29-10-2024,,,50,OPD,
2121,29-10-2024,TIPPER,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 60 Days  ], NIFEDIPINE 30MG SUSTAIN RELEASE[ NIFEMAX SR 30MG | 30MG | Tablet | BDS |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], NIFEDIPINE 30MG SUSTAIN RELEASE[ NIFEMAX SR 30MG | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,29-10-2024,29-10-2024,,,10,OPD,
2122,29-10-2024,NIC,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",,,29-10-2024,29-10-2024,,,40,OPD,
2190,29-10-2024,AGEGE ZONE SIX,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Retired,,29-10-2024,29-10-2024,,,60,OPD,
2218,29-10-2024,"GBAWE , TOP BULEME ",47 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,I10.00 [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | BID |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ]",,,29-10-2024,29-10-2024,,,10,OPD,
2261,29-10-2024,LAPAZ NEW MARKET,46 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Non-Insured,,,FOOD VENDOR,,29-10-2024,29-10-2024,,,30,OPD,
2404,29-10-2024,MALLAM STATIOIN,66 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,"I15.9 [Secondary hypertension, unspecified]  ==> OLD",No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]",,BUSINESS PERSON,,29-10-2024,29-10-2024,,,20,OPD,
2546,29-10-2024,madina,59 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E09.40 [Drug or chemical induced diabetes mellitus with neurological complications with diabetic neuropathy, unspecified]  ==> NEW",,No,Insured,"PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ]","PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",seamstress,,29-10-2024,29-10-2024,,,0,OPD,
2617,28-10-2024,WEIJA ITS,55 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E10.65 [Type 1 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,,,,,28-10-2024,28-10-2024,,,60,OPD,
2635,28-10-2024,WEIJA   ROMAN,47 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,,No,Insured,,,,,28-10-2024,28-10-2024,,,50,OPD,
2640,28-10-2024,TETEGU ,68 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 30 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | OD |  For 30 Days  ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",TRADER,,28-10-2024,28-10-2024,,,15,OPD,
2685,28-10-2024,"DARKUMAN , NEAR AFROPA HOUSE ",52 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,28-10-2024,28-10-2024,,,0,OPD,
2699,28-10-2024,KWASHIBU,55 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | TDS |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ]",,,28-10-2024,28-10-2024,,,10,OPD,
2700,28-10-2024,KASOA,53 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ]",,TRADER,,28-10-2024,28-10-2024,,,0,OPD,
2701,28-10-2024,ablekuman,69 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | BID |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ]","METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,28-10-2024,28-10-2024,,,0,OPD,
2746,28-10-2024,Weija water works ,59 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | TDS |  For 5 Days  ]","DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ]",,,28-10-2024,28-10-2024,,,10,OPD,
2759,28-10-2024,AWOSHIE MANGOASE,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,28-10-2024,28-10-2024,,,10,OPD,
2760,28-10-2024,WEIJA,79 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,28-10-2024,28-10-2024,,,10,OPD,
2762,28-10-2024,agape,64 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.36 [Type 2 diabetes mellitus with diabetic cataract]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,28-10-2024,28-10-2024,,,0,OPD,
2782,28-10-2024,"MALLAM
NEW LIFE SCHOOL",74 Year(s),Male,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,28-10-2024,28-10-2024,,,60,OPD,
2801,28-10-2024,ABLEKUMAH-FAN MILK,66 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Pensioner,,28-10-2024,28-10-2024,,,15,OPD,
2829,28-10-2024,AWOSHIE,39 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,,No,Insured,"VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 0 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 0 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 0 Days  ], FLUCONAZOLE CAPSULE 150MG[ FLUCONAZOLE | 150MG | Capsule | Stat |  For 1 Days  ], CLOTRIMAZOLE CREAM,1%[ CLOTRIMAZOLE | 1% 30G | Cream | BDS |  For 5 Days  ]","VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], FLUCONAZOLE CAPSULE 150MG[ FLUCONAZOLE | 150MG | Capsule ], CLOTRIMAZOLE CREAM,1%[ CLOTRIMAZOLE | 1% 30G | Cream ]",,,28-10-2024,28-10-2024,,,0,OPD,
2859,28-10-2024,"SCC
BLOCK FACTORY",67 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,28-10-2024,28-10-2024,,,10,OPD,
2968,28-10-2024,"SANTA MARIA , A-LANG ",57 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,"GLICLAZIDE [ DIAMICRON | 60MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","GLICLAZIDE [ DIAMICRON | 60MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",MECHANIC,,28-10-2024,28-10-2024,,,10,OPD,
3007,28-10-2024,TUBA-TOLL BOTH,61 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], AMLODIPINE(ASOMEX) 2.5MG[ AMLODIPINE(ASOMEX) | 2.5MG | Tablet | OD |  For 90 Days  ]",,,,28-10-2024,28-10-2024,,,10,OPD,
3101,28-10-2024,AGEGE ZONE SIX,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Retired,,28-10-2024,28-10-2024,,,80,OPD,
3117,28-10-2024,kasoa,64 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,28-10-2024,28-10-2024,,,0,OPD,
3123,28-10-2024,apleku,62 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E14.9 [Unspecified diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BDS |  For 5 Days  ]","DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ]",,,28-10-2024,28-10-2024,,,10,OPD,
3137,28-10-2024,kasoa,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 60 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ]",,,28-10-2024,28-10-2024,,,0,OPD,
3326,28-10-2024,KANESHIE,51 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,TRADER,,28-10-2024,28-10-2024,,,0,OPD,
3618,28-10-2024,PAMBROUS,33 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection | Stat |  For 1 Days  ], HYOSCINE BUTYLBROMIDE INJECTION 20MG[ BUSCOPAN | 20MG/ML | Injection | Stat |  For 1 Days  ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion | BDS |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | BDS |  For 1 Days  ]","OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection ], HYOSCINE BUTYLBROMIDE INJECTION 20MG[ BUSCOPAN | 20MG/ML | Injection ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",,,28-10-2024,28-10-2024,,,290,OPD,
3697,27-10-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,27-10-2024,27-10-2024,,,10,OPD,
3726,27-10-2024,AGEGE ZONE SIX,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Retired,,27-10-2024,27-10-2024,,,60,OPD,
3883,26-10-2024,KWASHIEMAN,57 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,,,,,26-10-2024,26-10-2024,,,10,OPD,
3984,26-10-2024,SANTA MARIA- JAHLOVE,82 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,,No,Insured,CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion | BDS |  For 1 Days  ],CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion ],,,26-10-2024,26-10-2024,,,135,OPD,
3994,26-10-2024,AGEGE ZONE SIX,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Retired,,26-10-2024,26-10-2024,,,60,OPD,
4005,26-10-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E10.621 [Type 1 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,26-10-2024,26-10-2024,,,10,OPD,
4060,26-10-2024,GBAWE ZERO,43 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | TID |  For 15 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],TRADER,,26-10-2024,26-10-2024,,,70,OPD,
4119,25-10-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,25-10-2024,25-10-2024,,,20,OPD,
4189,25-10-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,25-10-2024,25-10-2024,,,0,OPD,
4197,25-10-2024,MALLAM KOKROKO,61 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E10.22 [Type 1 diabetes mellitus with diabetic chronic kidney disease]  ==> NEW,"I10.00 [Essential (primary) hypertension]  ==> NEW, N18.5 [Chronic kidney disease, stage 5]  ==> NEW",No,Insured,"GLICLAZIDE [ DIAMICRON | 60MG | Tablet | OD |  For 60 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | BDS |  For 60 Days  ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet | BDS |  For 60 Days  ]","GLICLAZIDE [ DIAMICRON | 60MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet ]",STORE KEEPEER,,25-10-2024,25-10-2024,,,0,OPD,
4326,25-10-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Child,,No Outcome,NA ,E10.621 [Type 1 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,25-10-2024,25-10-2024,,,10,OPD,
4599,25-10-2024,"GBAWE
CP",49 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],TRADER,,25-10-2024,25-10-2024,,,110,OPD,
4668,25-10-2024,"ABLEKUMA
MAAME NKRAN",39 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,"O24.410 [Gestational diabetes mellitus in pregnancy, diet controlled]  ==> OLD",,No,Insured,,,,,25-10-2024,25-10-2024,,,50,OPD,
4754,25-10-2024,TETEGU ,68 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],TRADER,,25-10-2024,25-10-2024,,,0,OPD,
5043,24-10-2024,gbawe bulemi,71 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 0 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,24-10-2024,24-10-2024,,,10,OPD,3143/16
5048,24-10-2024,mc carthy,79 Year(s),Female,SPECIALIST CLINIC ,CONSULTATION REVIEW (ADULT),,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, D50.9 [Iron deficiency anaemia, unspecified]  ==> OLD",No,Insured,"GLICLAZIDE [ DIAMICRON | 60MG | Tablet | Daily |  For 30 Days  ], FERROUS GLUCONATE  SYRUP[ TOT-HEMA (IN AMPOULES) | 10ML | Syrup | BID |  For 30 Days  ]",,,,24-10-2024,24-10-2024,,,180,OPD,
5062,24-10-2024,accra central police station,48 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",seamstress,,24-10-2024,24-10-2024,,,10,OPD,
5117,24-10-2024,ODORKOR-ALABAMA,53 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> OLD,,No,Non-Insured,,,ELECTRONICS,,24-10-2024,24-10-2024,,,60,OPD,
5126,24-10-2024,kasoa,62 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,24-10-2024,24-10-2024,,,10,OPD,
5136,24-10-2024,KALABULE,27 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],TRADER,,24-10-2024,24-10-2024,,,60,OPD,
5142,24-10-2024,TETEGU-2ND TRANSFORMAER,56 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 60 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 60 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Nocte |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ]",,,24-10-2024,24-10-2024,,,10,OPD,
5148,24-10-2024,mccarthy,67 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,24-10-2024,24-10-2024,,,10,OPD,
5188,24-10-2024,"AGAPE -
ABLEKUMA",57 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,24-10-2024,24-10-2024,,,60,OPD,
5253,24-10-2024,KANESHIE,51 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,TRADER,,24-10-2024,24-10-2024,,,0,OPD,
5273,24-10-2024,new bortianor,50 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,24-10-2024,24-10-2024,,,10,OPD,
5307,24-10-2024,"BORTIANOR , AYIGBE TOWN ",33 Year(s),Female,EYE CLINIC ,Consultation Adult ,,No Outcome,NA ,"E08.3293 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, bilateral]  ==> NEW",,Yes,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 1 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",FOOD SELLER,,24-10-2024,24-10-2024,,,150,OPD,
5340,24-10-2024,KASOA TUBA,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,K29.1 [Other acute gastritis]  ==> RECURRING,No,Non-Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ],  (NUGEL  O) ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETA[ NUGEL - O  | 200ML | Suspension | TDS |  For 5 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | BDS |  For 7 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],  (NUGEL  O) ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETA[ NUGEL - O  | 200ML | Suspension ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ]",,,24-10-2024,24-10-2024,,,10,OPD,
5353,24-10-2024,"IRON CITY
AMANFRO",44 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",TRADER,,24-10-2024,24-10-2024,,,0,OPD,
5411,24-10-2024,LAPAZ NEW MARKET,46 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Non-Insured,,,FOOD VENDOR,,24-10-2024,24-10-2024,,,30,OPD,
5439,24-10-2024,ABLEKUMA OLEBU,57 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,24-10-2024,24-10-2024,,,50,OPD,
5446,24-10-2024,OLD  BARRIER- NEAR  TRANSFORMER,76 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.10 [Type 2 diabetes mellitus with ketoacidosis without coma]  ==> NEW,,No,Non-Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ]",,,,24-10-2024,24-10-2024,,,190,OPD,
5480,24-10-2024,AGEGE ZONE SIX,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Retired,,24-10-2024,24-10-2024,,,70,OPD,
5797,24-10-2024,SANTA MARIA,82 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,"A41.9 [Sepsis, unspecified]  ==> OLD",No,Insured,"CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | OD |  For 1 Days  ]",,,,24-10-2024,24-10-2024,,,125,OPD,
5802,24-10-2024,"AWOSHIE
MANGOASE",50 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.69 [Type 2 diabetes mellitus with other specified complication]  ==> NEW,"A41.9 [Sepsis, unspecified]  ==> NEW",No,Insured,"OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection | BDS |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | Stat |  For 1 Days  ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | QID |  For 1 Days  ]","OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection ]",TRADER,,24-10-2024,24-10-2024,,,175,OPD,
5821,23-10-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,23-10-2024,23-10-2024,,,0,OPD,
5822,23-10-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E10.621 [Type 1 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,23-10-2024,23-10-2024,,,0,OPD,
5856,23-10-2024,WEIJA CATERPILLAR ROAD,61 Year(s),Female,EYE CLINIC ,Consultation Adult ,,No Outcome,NA ,E11.36 [Type 2 diabetes mellitus with diabetic cataract]  ==> NEW,,No,Insured,,,TRADER,,23-10-2024,23-10-2024,,,120,OPD,
5889,23-10-2024,weija,54 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,,,,,23-10-2024,23-10-2024,,,0,OPD,
5895,23-10-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Child,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,23-10-2024,23-10-2024,,,0,OPD,
6030,23-10-2024,ODORKOR-ALABAMA,53 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> OLD,,No,Non-Insured,,,ELECTRONICS,,23-10-2024,23-10-2024,,,60,OPD,
6066,23-10-2024,AWOSHIE,77 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E11.8 [Type 2 diabetes mellitus with unspecified complications]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K27.9 [Peptic ulcer, site unspecified: Unspecified as acute or chronic, without haemorrhage or perforation]  ==> OLD",No,Insured,,,,,23-10-2024,23-10-2024,,,10,OPD,
6164,23-10-2024,"SCC
RED TOP",53 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | TDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",TRADER,,23-10-2024,23-10-2024,,,10,OPD,
6184,23-10-2024,KASOA,69 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E10.621 [Type 1 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,,,23-10-2024,23-10-2024,,,0,OPD,
6436,23-10-2024,AGEGE ZONE SIX,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Retired,,23-10-2024,23-10-2024,,,70,OPD,
6513,23-10-2024,"BORTIANOR
SHOPPRITE",59 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Non-Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],Unemployed,,23-10-2024,23-10-2024,,,70,OPD,
6745,22-10-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E10.621 [Type 1 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,22-10-2024,22-10-2024,,,0,OPD,
6766,22-10-2024,GBAWE,56 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ]",,TRADER,,22-10-2024,22-10-2024,,,10,OPD,
6812,22-10-2024,"KWASHIEMAN
ADE JUNCTION",62 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E10.65 [Type 1 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,,,,,22-10-2024,22-10-2024,,,60,OPD,
6854,22-10-2024,WEIJA ITS,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,"E08.3211 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, right eye]  ==> OLD",,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,22-10-2024,22-10-2024,,,10,OPD,
6858,22-10-2024,upper weija,52 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule | 0-0-1 |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | OD |  For 14 Days  ]","IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ]",,,22-10-2024,22-10-2024,,,10,OPD,
6894,22-10-2024,"OLEBU
MASALACHI",63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]",,Teacher,,22-10-2024,22-10-2024,,,10,OPD,
6903,22-10-2024,Broadcasing ,60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,"E08.3399 [Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye]  ==> OLD",I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,22-10-2024,22-10-2024,,,0,OPD,
6947,22-10-2024,TOP BASE-GBAWE,50 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,K29.1 [Other acute gastritis]  ==> OLD,No,Insured,"OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | BDS |  For 7 Days  ],  (NUGEL  O) ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETA[ NUGEL - O  | 200ML | Suspension | TDS |  For 5 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ], CEFUROXIME INJECTION 750MG[ CEFUROXIME | 750MG | Injection | Stat |  For 1 Days  ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet | BDS |  For 7 Days  ], CLOTRIMAZOLE 500MG PESSARY (GOGYNAX)[ GOGYNAX | 500MG | Pessary | OD |  For 1 Days  ]","OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ],  (NUGEL  O) ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETA[ NUGEL - O  | 200ML | Suspension ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CEFUROXIME INJECTION 750MG[ CEFUROXIME | 750MG | Injection ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet ], CLOTRIMAZOLE 500MG PESSARY (GOGYNAX)[ GOGYNAX | 500MG | Pessary ]",business woman,,22-10-2024,22-10-2024,,,5,OPD,
7002,22-10-2024,AGEGE ZONE SIX,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Retired,,22-10-2024,22-10-2024,,,70,OPD,
7060,22-10-2024,ASOFA,42 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",,,22-10-2024,22-10-2024,,,10,OPD,
7087,22-10-2024,GBAWE,65 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 20 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Stat |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ]",Unemployed,,22-10-2024,22-10-2024,,,20,OPD,
7225,22-10-2024,UPPER WEIJA,63 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.8 [Type 2 diabetes mellitus with unspecified complications]  ==> NEW,"N39.0 [Urinary tract infection, site not specified]  ==> NEW, G89.11 [Acute pain due to trauma]  ==> NEW",No,Non-Insured,"TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 5 Days  ], OSTEOCARE TABLET[ OSTEOCARE |  | Tablet | OD |  For 30 Days  ]","TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], OSTEOCARE TABLET[ OSTEOCARE |  | Tablet ]",TRADER,,22-10-2024,22-10-2024,,,70,OPD,
7469,22-10-2024,SOWUTUOM,48 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | OD |  For 1 Days  ]",,,,22-10-2024,22-10-2024,,,153,OPD,
7677,21-10-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,21-10-2024,21-10-2024,,,10,OPD,
7683,21-10-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E10.621 [Type 1 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,21-10-2024,21-10-2024,,,0,OPD,
7736,21-10-2024,AGEGE ZONE SIX,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Retired,,21-10-2024,21-10-2024,,,70,OPD,
7771,21-10-2024,papase,75 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,21-10-2024,21-10-2024,,,0,OPD,
7772,21-10-2024,gbawe bulemi,68 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,21-10-2024,21-10-2024,,,10,OPD,
7773,21-10-2024,KASOA-CP,64 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,Unemployed,,21-10-2024,21-10-2024,,,60,OPD,
7774,21-10-2024,KASOA COLUMBA,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,"E08.3211 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, right eye]  ==> OLD",,No,Non-Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,21-10-2024,21-10-2024,,,10,OPD,
7776,21-10-2024,"AWOSHIE, A-LANG",57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,21-10-2024,21-10-2024,,,10,OPD,
7778,21-10-2024,dansoman,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 60 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 60 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ]",,,21-10-2024,21-10-2024,,,0,OPD,
7785,21-10-2024,"ACCRA  - 
NEW TOWN ",54 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE 30MG SUSTAIN RELEASE[ NIFEMAX SR 30MG | 30MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ]","NIFEDIPINE 30MG SUSTAIN RELEASE[ NIFEMAX SR 30MG | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,21-10-2024,21-10-2024,,,60,OPD,
7795,21-10-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,21-10-2024,21-10-2024,,,20,OPD,
7844,21-10-2024,mallam,69 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ]",,,21-10-2024,21-10-2024,,,10,OPD,
7847,21-10-2024,lower mccarthy,69 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | BDS |  For 90 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | BDS |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]",,,,21-10-2024,21-10-2024,,,10,OPD,
7853,21-10-2024,UPPER WEIJA,48 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 0 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 0 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 0 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",,,21-10-2024,21-10-2024,,,20,OPD,
7858,21-10-2024,nurses quarters,73 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ]","BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,21-10-2024,21-10-2024,,,0,OPD,
7940,21-10-2024,KANESHIE,51 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,,No,Insured,"INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ], SODIUM CHLORIDE NASAL DROP[ SALINE | 0.9% 10ML | Drops | Stat |  For 1 Days  ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | Stat |  For 1 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE TABLET 10MG(SLOW RELEASE)[ NIFEDIPINE RETARD | 10MG | Tablet | Daily |  For 30 Days  ]","INSULIN SOLUBLE HM100UNITS/ML[  |  |  ], SODIUM CHLORIDE NASAL DROP[ SALINE | 0.9% 10ML | Drops ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 10MG(SLOW RELEASE)[ NIFEDIPINE RETARD | 10MG | Tablet ]",TRADER,,21-10-2024,21-10-2024,,,10,OPD,
7987,21-10-2024,KWASHIBU,55 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 7 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,21-10-2024,21-10-2024,,,10,OPD,
8003,21-10-2024,KASOA OLD BARRIER-KINGDOM HALL ROAD,49 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,beautician,,21-10-2024,21-10-2024,,,50,OPD,
8029,21-10-2024,DOME GYMM,57 Year(s),Female,EYE CLINIC ,Consultation Adult ,,No Outcome,NA ,E11.36 [Type 2 diabetes mellitus with diabetic cataract]  ==> NEW,,No,Insured,,,FOOD VENDOR,,21-10-2024,21-10-2024,,,0,OPD,
8070,21-10-2024,WEIJA,46 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 60 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], FLUCLOXACILLIN CAPSULE 250MG[ FLUCLOXACILLIN | 250MG | Capsule | QID |  For 7 Days  ], CLOTRIMAZOLE CREAM,1%[ CLOTRIMAZOLE | 1% 30G | Cream | BDS |  For 7 Days  ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet | Nocte |  For 5 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], FLUCLOXACILLIN CAPSULE 250MG[ FLUCLOXACILLIN | 250MG | Capsule ], CLOTRIMAZOLE CREAM,1%[ CLOTRIMAZOLE | 1% 30G | Cream ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet ]",,,21-10-2024,21-10-2024,,,0,OPD,
8073,21-10-2024,AMERICAN TOWN,69 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.42 [Type 2 diabetes mellitus with diabetic polyneuropathy]  ==> OLD,,No,Insured,"JOINT FORTIS[ JOINT FORTIS |  | Tablet | OD |  For 30 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 0 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ]","JOINT FORTIS[ JOINT FORTIS |  | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ]",,,21-10-2024,21-10-2024,,,10,OPD,
8086,21-10-2024,WEIJA-SCH JUNCTION,56 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,21-10-2024,21-10-2024,,,10,OPD,
8104,21-10-2024,NIC,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ]",,,,21-10-2024,21-10-2024,,,10,OPD,
8190,21-10-2024,ODORKOR-ALABAMA,53 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> OLD,,No,Non-Insured,,,ELECTRONICS,,21-10-2024,21-10-2024,,,60,OPD,
8238,21-10-2024,BORTIANOR-ATTA STREET,62 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ],  (NUGEL  O) ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETA[ NUGEL - O  | 200ML | Suspension | BID |  For 5 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | BDS |  For 7 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ],  (NUGEL  O) ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETA[ NUGEL - O  | 200ML | Suspension ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,21-10-2024,21-10-2024,,,0,OPD,7734/16  MR-6B-C4-17
8507,21-10-2024,KASOA BRAODCASTING,64 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 0 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 0 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 0 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 30 Days  ]",,Unemployed,,21-10-2024,21-10-2024,,,0,OPD,
8519,21-10-2024,DANSOMAN,56 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],TRADER,,21-10-2024,21-10-2024,,,0,OPD,
8541,21-10-2024,KASOA NEW MARKET,48 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> NEW,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ]",,business man,,21-10-2024,21-10-2024,,,0,OPD,
8772,20-10-2024,LAPAZ NEW MARKET,46 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Non-Insured,,,FOOD VENDOR,,20-10-2024,20-10-2024,,,0,OPD,
8793,20-10-2024,KASOA OFANKOR,60 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,TRADER,,20-10-2024,20-10-2024,,,0,OPD,
8915,19-10-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,19-10-2024,19-10-2024,,,0,OPD,
8921,19-10-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E10.621 [Type 1 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,19-10-2024,19-10-2024,,,10,OPD,
8934,19-10-2024,weija,54 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,,,,,19-10-2024,19-10-2024,,,30,OPD,
8963,19-10-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,19-10-2024,19-10-2024,,,30,OPD,
8980,19-10-2024,AGEGE ZONE SIX,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Retired,,19-10-2024,19-10-2024,,,70,OPD,
9092,19-10-2024,RED TOP BORTIANOR,67 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,"E11.40 [Type 2 diabetes mellitus with diabetic neuropathy, unspecified]  ==> OLD",,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 14 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],Unemployed,,19-10-2024,19-10-2024,,,0,OPD,
9145,19-10-2024,MALLAM JUNCTION,44 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,Z87.11 [Personal history of peptic ulcer disease]  ==> NEW,No,Non-Insured,"GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection | Stat |  For 1 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | BDS |  For 14 Days  ], AMOXICILLIN CAPSULE 500MG[ AMOXICILIN | 500MG | Capsule | BDS |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 14 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 31 Days  ]","GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], AMOXICILLIN CAPSULE 500MG[ AMOXICILIN | 500MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,19-10-2024,19-10-2024,,,95,OPD,
9230,18-10-2024,ODORKOR-ALABAMA,53 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> OLD,,No,Non-Insured,,,ELECTRONICS,,18-10-2024,18-10-2024,,,60,OPD,
9279,18-10-2024,AGEGE ZONE SIX,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Retired,,18-10-2024,18-10-2024,,,60,OPD,
9300,18-10-2024,GBAWE BULEMIN,83 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> NEW,I10.00 [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ]",,,18-10-2024,18-10-2024,,,10,OPD,
9316,18-10-2024,TETEGU,53 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.610 [Diabetes mellitus due to underlying condition with diabetic neuropathic arthropathy]  ==> OLD,M79.1 [Myalgia]  ==> RECURRING,No,Insured,"DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BDS |  For 5 Days  ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule | BDS |  For 5 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], SIMPLE LINCTUS ADULT BPC [ SIMPLE LINTUS ADULT | 100ML | Mixture | TDS |  For 5 Days  ], SODIUM CHLORIDE NASAL DROP[ SALINE | 0.9% 10ML | Drops | TDS |  For 5 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | BDS |  For 14 Days  ]","DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], SIMPLE LINCTUS ADULT BPC [ SIMPLE LINTUS ADULT | 100ML | Mixture ], SODIUM CHLORIDE NASAL DROP[ SALINE | 0.9% 10ML | Drops ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ]",TRADER,,18-10-2024,18-10-2024,,,65,OPD,
9372,18-10-2024,ABLEKUMA,58 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.8 [Type 2 diabetes mellitus with unspecified complications]  ==> OLD,"I64.00 [Stroke, not specified as haemorrhage or infarction]  ==> OLD, I10.00 [Essential (primary) hypertension]  ==> OLD",No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,18-10-2024,18-10-2024,,,65,OPD,
9381,18-10-2024,"ODORKOR
BUSIA",45 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E10.40 [Type 1 diabetes mellitus with diabetic neuropathy, unspecified]  ==> OLD",,No,Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ],,TRADER,,18-10-2024,18-10-2024,,,0,OPD,
9779,18-10-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E10.621 [Type 1 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,18-10-2024,18-10-2024,,,0,OPD,
9903,17-10-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,17-10-2024,17-10-2024,,,0,OPD,
9908,17-10-2024,KASOA COLUMBA,63 Year(s),Female,SPECIALIST CLINIC ,CONSULTATION (ADULT),,No Outcome,NA ,"E08.3211 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, right eye]  ==> OLD",,No,Non-Insured,,,TRADER,,17-10-2024,17-10-2024,,,180,OPD,
9925,17-10-2024,TUBA,83 Year(s),Male,SPECIALIST CLINIC ,CONSULTATION (ADULT),,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,17-10-2024,17-10-2024,,,180,OPD,
9967,17-10-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,17-10-2024,17-10-2024,,,0,OPD,
9992,17-10-2024,mc carthy,79 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet | BDS |  For 30 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], APTIZOOOM[ APTIZOOOM |  | Syrup | OD |  For 5 Days  ]","TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], APTIZOOOM[ APTIZOOOM |  | Syrup ]",,,17-10-2024,17-10-2024,,,10,OPD,
10000,17-10-2024,kasoa,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,17-10-2024,17-10-2024,,,10,OPD,
10002,17-10-2024,kasoa,60 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | OD |  For 30 Days  ]","PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet ]",,,17-10-2024,17-10-2024,,,10,OPD,
10003,17-10-2024,TETEGU,53 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ]",,,,17-10-2024,17-10-2024,,,10,OPD,
10004,17-10-2024,SANTA MARIA AUNTIE AKU,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.649 [Diabetes mellitus due to underlying condition with hypoglycemia without coma]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE 30MG SUSTAIN RELEASE[ NIFEMAX SR 30MG | 30MG | Tablet | OD |  For 30 Days  ], BENDROFLUMETHIAZIDE TABLET 5MG[ BENDROFLUMETHIAZIDE | 5MG | Tablet | OD |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","NIFEDIPINE 30MG SUSTAIN RELEASE[ NIFEMAX SR 30MG | 30MG | Tablet ], BENDROFLUMETHIAZIDE TABLET 5MG[ BENDROFLUMETHIAZIDE | 5MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,17-10-2024,17-10-2024,,,0,OPD,
10008,17-10-2024,"OLD BARIER 
SH BREAD",50 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 1 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",TRADER,,17-10-2024,17-10-2024,,,70,OPD,
10013,17-10-2024,KOKROBITE,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,17-10-2024,17-10-2024,,,10,OPD,
10014,17-10-2024,KASOA-CP,64 Year(s),Female,SPECIALIST CLINIC ,CONSULTATION (ADULT),,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,Unemployed,,17-10-2024,17-10-2024,,,170,OPD,
10016,17-10-2024,JOHN TEYE,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> OLD,,No,Insured,"PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BID |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 5 Days  ]",,,,17-10-2024,17-10-2024,,,0,OPD,
10086,17-10-2024,MENDS KRROM,68 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,17-10-2024,17-10-2024,,,50,OPD,
10134,17-10-2024,AGEGE ZONE SIX,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Retired,,17-10-2024,17-10-2024,,,60,OPD,
10276,17-10-2024,NEW BORTIANOR,51 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],INSURANCE AGENT,,17-10-2024,17-10-2024,,,10,OPD,
10284,17-10-2024,MANGOLINE,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"VITAMIN B1+B2+B6+B12+GLUTAMIC ACID[ NEURO-MIN PLUS |  | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 60 Days  ]","VITAMIN B1+B2+B6+B12+GLUTAMIC ACID[ NEURO-MIN PLUS |  | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ]",,,17-10-2024,17-10-2024,,,10,OPD,
10306,17-10-2024,"GBAWE
BULEMIN",48 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,17-10-2024,17-10-2024,,,50,OPD,
10330,17-10-2024,NYENYANYO,62 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",Pensioner,,17-10-2024,17-10-2024,,,0,OPD,
10397,17-10-2024,tuba,51 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,TRADER,,17-10-2024,17-10-2024,,,50,OPD,
10409,17-10-2024,OBLOGO,60 Year(s),Male,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,Mason,,17-10-2024,17-10-2024,,,50,OPD,
10446,17-10-2024,BULEMIN,76 Year(s),Male,EYE CLINIC ,Consultation Adult ,,No Outcome,NA ,E08.36 [Diabetes mellitus due to underlying condition with diabetic cataract]  ==> OLD,,No,Insured,,,,,17-10-2024,17-10-2024,,,50,OPD,
10452,17-10-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E10.621 [Type 1 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,17-10-2024,17-10-2024,,,0,OPD,
10460,17-10-2024,KWASHIEMAN SCH JUNCTION,87 Year(s),Male,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,AGED,,17-10-2024,17-10-2024,,,50,OPD,
